Concepedia

Carlos I. Amaya-Chanaga

CI

4

Publications

191

Citations

4

H-Index

2015

Active since

Affiliations

CancerCare(Current)

Carlos I. Amaya-Chanaga is an author at CancerCare specializing in liver physiology, hepatology, and health sciences.

Top concepts

Publications per year

2015–2021

4

Publications

4

Ulocuplumab (BMS-936564 / MDX1338): a fully human anti-CXCR4 antibody induces cell death in chronic lymphocytic leukemia mediated through a reactive oxygen species-dependent pathway

Manoj Kumar Kashyap, Deepak Kumar, Harrison Jones et al. · Oncotarget · 2015 · 83 citations · Full text

Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia

Manoj Kumar Kashyap, Carlos I. Amaya-Chanaga, Deepak Kumar et al. · Journal of Hematology & Oncology · 2017 · 62 citations · Full text

Prognostic Testing and Treatment Patterns in Chronic Lymphocytic Leukemia in the Era of Novel Targeted Therapies: Results From the informCLL Registry

Anthony R. Mato, Jacqueline C. Barrientos, Nilanjan Ghosh et al. · Clinical Lymphoma Myeloma & Leukemia · 2019 · 33 citations · Full text

Post hoc analysis in patients (pts) with unresectable hepatocellular carcinoma (uHCC) who progressed to Child-Pugh B (CPB) liver function in the phase III REFLECT study of lenvatinib (LEN).

Jasmine Huynh, May Thet Cho, Edward Kim et al. · Journal of Clinical Oncology · 2021 · 13 citations

, , +21

Rows per page

1–4 of 4